Mesa Royalty Trust MTR Q4 2025 Earnings Modest EPS as Royalty Income Continues to Reflect Stable Production BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Loss and Strategic Progress PLMR Q1 2026 Earnings Palomar Holdings Beats EPS Estimates by 301 Puma Biotechnology PBYI Q1 2026 Earnings EPS Beats Estimates by Wide Margin Shares Rise ACTU Q1 2026 Earnings WiderThanExpected Loss Weighs on Investor Sentiment IRIDEX Q1 2026 Earnings Narrowed Loss Surpasses Estimates Amid Operational Focus